Scientists uncover mechanism for melanoma drug resistance
Cancer is tough to kill and has many ways of evading the drugs used by oncologists to try and eliminate it.
Cancer
Mar 06, 2012 |
5 / 5 (4) |
0
|
Genomic sequencing identifies mutant 'drivers' of common brain tumor
Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of brain tumors known as meningiomas, a finding that could lead to the first effective drug treatments for the tumors, report ...
Genetics
Jan 22, 2013 |
not rated yet |
0
|
Communication is key to medication adherence
(Medical Xpress)—Even the best medicines in the world can be rendered ineffective if they are not taken as prescribed. The problem known as medication "non-adherence" is a major health issue in the United ...
Health
Jan 02, 2013 |
not rated yet |
0
|
US childhood obesity dips for first time in decades
Obesity rates among small children may finally be on the decline after more than tripling in the United States the past 30 years, a study out Wednesday indicated.
Overweight and Obesity
Dec 27, 2012 |
1 / 5 (1) |
0
Bilirubin can prevent damage from cardiovascular disease
Each year, about 610,000 Americans suffer their first heart attack, according to the Centers for Disease Control and Prevention. Heart attacks and other symptoms of cardiovascular disease can be caused when ...
Cardiology
Dec 06, 2012 |
4.5 / 5 (2) |
0
|
Antiseptic products can be contaminated, study says
(HealthDay)—Antiseptics are meant to keep bacteria and other pathogens from entering the body through breaks in the skin, but sometimes these products can be contaminated with the very organisms they're ...
Medications
Dec 06, 2012 |
4.5 / 5 (2) |
0
|
Adult antiviral drug effective in suppressing hepatitis B in teens
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December ...
Diseases, Conditions, Syndromes
Dec 05, 2012 |
5 / 5 (1) |
0
|
Expert: Time to break the beta blocker habit?
First developed in the 1950s, beta blockers have been a mainstay in medicine for decades, used to treat everything from heart disease to stage fright to glaucoma. But some older classes of beta blockers are ...
Cardiology
Nov 12, 2012 |
not rated yet |
1
|
Scientific progress could be casualty in public health vs. privacy debate over newborn blood samples
The tremendous potential public health benefits of research with blood samples left over after routine newborn screening must not be lost amidst controversy and litigation, say medical and bioethics experts in a commentary ...
Other
Nov 07, 2012 |
not rated yet |
0
|
New study validates activity of rare genetic variant in glioma
Researchers at Moffitt Cancer Center working with colleagues at three other institutions have validated a link between a rare genetic variant and the risk of glioma, the most common and lethal type of brain tumor. The validation ...
Genetics
Jul 02, 2012 |
not rated yet |
0
|
Minimally invasive approach to weight-loss surgery reduces complications, study shows
A study by researchers at Stanford University Medical Center has found that a popular weight-loss operation is safer and reduces hospital bills when done with minimally invasive techniques rather than open surgery, which ...
Surgery
Jun 18, 2012 |
5 / 5 (1) |
0
|
Progress against HIV thwarted by patients' unmet needs
In a groundbreaking study published last year, scientists reported that effective treatment with HIV medications not only restores health and prolongs life in many HIV-infected patients, but also curtails transmission to ...
HIV & AIDS
Apr 26, 2012 |
not rated yet |
0
|
New way to treat strokes is a 'game-changer,' docs say
A new generation of devices could significantly improve care for patients who have some of the most devastating types of strokes.
Cardiology
Apr 10, 2012 |
1 / 5 (1) |
0
Second mutation in BRAF-mutated melanoma doesn't contribute to resistance
A second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma does not contribute to resistance to BRAF inhibitor drugs, a finding that runs counter to what scientists expected to be true.
Cancer
Apr 01, 2012 |
5 / 5 (1) |
0
|
Researchers discover way to block body's response to cold
Researchers at St. Joseph's Hospital and Medical Center in Phoenix, Arizona, in collaboration with Amgen Inc. and several academic institutions, have discovered a way to block the body's response to cold using a drug. This ...
Neuroscience
Mar 01, 2012 |
5 / 5 (1) |
0
|
